| Product NDC: | 60432-126 |
| Proprietary Name: | Megestrol Acetate |
| Non Proprietary Name: | Megestrol Acetate |
| Active Ingredient(s): | 40 mg/mL & nbsp; Megestrol Acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60432-126 |
| Labeler Name: | Morton Grove Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076721 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050209 |
| Package NDC: | 60432-126-08 |
| Package Description: | 240 mL in 1 BOTTLE, PLASTIC (60432-126-08) |
| NDC Code | 60432-126-08 |
| Proprietary Name | Megestrol Acetate |
| Package Description | 240 mL in 1 BOTTLE, PLASTIC (60432-126-08) |
| Product NDC | 60432-126 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Megestrol Acetate |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20050209 |
| Marketing Category Name | ANDA |
| Labeler Name | Morton Grove Pharmaceuticals, Inc. |
| Substance Name | MEGESTROL ACETATE |
| Strength Number | 40 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |